Literature DB >> 2164042

The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of tumor necrosis factor-induced neutrophil responses by receptor down-regulation.

B Schleiffenbaum1, J Fehr.   

Abstract

Despite numerous reports, the role of tumor necrosis factor (TNF) in polymorphonuclear leukocyte (PMN) function remains controversial. We found TNF to be a potent, pertussis toxin-independent stimulator of PMN adhesion (ED50 2.6 pM). TNF-stimulated PMN under adherent conditions released up to 65% of their transcobalamine content (ED50 3.9 pM) and increased their burst activity 10-fold (ED50 3.2 pM) as measured by the hexose monophosphate shunt, whereas PMN held in suspension hardly degranulated at all and only little burst activity was demonstrable. However, preincubation of PMN with TNF in suspension led to a decrease in cellular adhesiveness, degranulation, and burst activity in response to a secondary stimulus of TNF under adherent conditions, although cells remained fully responsive toward phorbol myristate acetate. A concomitant dose-dependent decline of TNF receptor numbers that correlated well with the inhibition of PMN function (r = 0.91) suggests receptor down-regulation as the mechanism of functional PMN deactivation. Remarkably, preincubation with other PMN stimuli such as N-formyl-methionyl-leucyl-phenylalanine, platelet-activating factor, leukotriene B4, complement component fragment 5a (C5a)/C5a (desarginated), and endotoxin also led to a reduction of TNF-specific PMN responses (cross-deactivation) from 35% (LTB4) to 90% (endotoxin), corresponding with the down-regulation of TNF receptors. Deactivation and receptor down-regulation are independent of pertussis toxin-sensitive G proteins and protein kinase C but seemed to depend on changes in calcium metabolism. Granulocyte hyporesponsiveness towards TNF in sepsis (with elevated blood levels of endotoxin and TNF) might be a mechanism of self-protection or, to the contrary, might impair a possibly central mode of host defense.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164042      PMCID: PMC296706          DOI: 10.1172/JCI114683

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  59 in total

Review 1.  Membrane receptors and hormone action.

Authors:  P Cuatrecasas; M D Hollenberg
Journal:  Adv Protein Chem       Date:  1976

2.  Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration.

Authors:  C W Smith; R Rothlein; B J Hughes; M M Mariscalco; H E Rudloff; F C Schmalstieg; D C Anderson
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

3.  The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness.

Authors:  E L Becker; H J Showell; P M Henson; L S Hsu
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

4.  Design of potent and specific inhibitors of carboxypeptidases A and B.

Authors:  M A Ondetti; M E Condon; J Reid; E F Sabo; H S Cheung; D W Cushman
Journal:  Biochemistry       Date:  1979-04-17       Impact factor: 3.162

5.  Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.

Authors:  H N Fernandez; T E Hugli
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

6.  Modulating influence of chemotactic factor-induced cell adhesiveness on granulocyte function.

Authors:  J Fehr; C Dahinden
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils.

Authors:  Y H Atkinson; W A Marasco; A F Lopez; M A Vadas
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

8.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

9.  In vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions. Studies based on the acute neutropenia of filtration leukophoresis.

Authors:  J Fehr; H S Jacob
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

10.  Selective neutrophil desensitization to chemotactic factors.

Authors:  J T O'Flaherty; D L Kreutzer; H J Showell; G Vitkauskas; E L Becker; P A Ward
Journal:  J Cell Biol       Date:  1979-03       Impact factor: 10.539

View more
  16 in total

1.  Characterization of TNF receptor subtype expression and signaling on pulmonary endothelial cells in mice.

Authors:  Szabolcs Bertok; Michael R Wilson; Anthony D Dorr; Justina O Dokpesi; Kieran P O'Dea; Nandor Marczin; Masao Takata
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-03-04       Impact factor: 5.464

Review 2.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

3.  Inhibitory effects of anticardiolipin antibodies on lymphocyte proliferation and neutrophil phagocytosis.

Authors:  C L Yu; K H Sun; C Y Tsai; S R Wang
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

4.  Tumor necrosis factor priming of peripheral blood neutrophils from rheumatoid arthritis patients.

Authors:  I C Kowanko; A Ferrante; G Clemente; P P Youssef; M Smith
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

5.  Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin.

Authors:  P Villa; G Sartor; M Angelini; M Sironi; M Conni; P Gnocchi; A M Isetta; G Grau; W Buurman; L J van Tits
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

6.  Inhibition of tumour necrosis factor alpha (TNF-alpha)-induced neutrophil respiratory burst by a TNF inhibitor.

Authors:  A Ferrante; B Hauptmann; P Seckinger; J M Dayer
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

7.  Leukocyte activation by isolated hyperthermic liver and limb perfusion due to malignancy.

Authors:  J P Arnestad; A Bengtsson; J P Bengtson; L Hafström; H Redl; G Schlag
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

8.  Suppression of the development of tumoricidal function in gamma interferon-treated human peripheral blood monocytes by lipopolysaccharide: the role of cyclooxygenase metabolites.

Authors:  E Chu; L C Casey; J E Harris; D P Braun
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

9.  Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines.

Authors:  Thierry Fumeaux; Julien Dufour; Sabine Stern; Jérôme Pugin
Journal:  Intensive Care Med       Date:  2004-09-11       Impact factor: 17.440

10.  Cytokine-induced (interleukins-3, -6 and -8 and tumour necrosis factor-beta) activation and deactivation of human neutrophils.

Authors:  J Brom; W König
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.